Earnings Per Share, Basic in USD/shares of Astria Therapeutics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Astria Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q3 2020 to Q3 2025.
  • Astria Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.55 USD/shares, a 31% decline year-over-year.
  • Astria Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -2 USD/shares, a 0.92% increase year-over-year.
  • Astria Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -1.68 USD/shares, a 30.6% increase from 2023.
  • Astria Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.42 USD/shares, a 31.8% increase from 2022.
  • Astria Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -3.55 USD/shares, a 85.6% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Astria Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$2 -$1 $0 -31% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 -$2 -$1 $0 -32.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 -$1 -$1 $0 -52.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$1 $0 +$0.49 +52.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 -$2 $0 +$0.21 +33.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 -$2 $0 +$0.02 +4.44% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 -$2 $0 +$0.02 +5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 -$2 -$1 $0 -46.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 -$2 -$1 +$0.24 +27.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$2 $0 +$0.41 +47.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$2 $0 +$0.78 +66.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$3 -$1 -$28 -102% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 $24.00 -$1 $0 -42.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $24.00 -$1 +$4.47 +83.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $19.00 -$1 +$44.40 +97.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$24 $27.00 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$1 +$2.75 +81.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$5 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$46 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 -$3 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10

Astria Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 +$0.74 +30.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 -$2 +$1.13 +31.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 -$4 +$21.00 +85.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-04
2021 -$25 -$12 -101% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$12 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.